Q

Board of Directors

Glenn P. Tobin, Ph.D.
Chairman of the Board and Director

Glenn P. Tobin is currently Chairman of the Board and was elected as a director in 2017. Mr. Tobin served as Senior Vice President-Accountable Care Solutions of The Advisory Board Company beginning in 2012. Soon after he was named Chief Executive Officer of Crimson, The Advisory Board Company’s health analytics division, until he retired in 2017. He was also Chief Operating Officer of CodeRyte, Inc. from 2010 to 2012 and held various executive positions with Cerner Corporation from 1998 to 2004. Additionally, Mr. Tobin was General Manager for Corporate Executive Board and was a consultant for McKinsey and Company.

Chairman of the Board
Chair of the Compensation Committee
Member of the Innovation and Technology Committee

J. Boyd Douglas
President, CEO and Director

Boyd Douglas began his career at CPSI in 1988. Boyd has served as President and Chief Executive Officer since 2006, and has also been a member of the Board of Directors since 2002. In addition to his current role, he has held several other positions at CPSI including Executive Vice President/Chief Operating Officer and Director of Programming Services. Boyd graduated from the University of the South with a Bachelor of Science in Mathematics.

David A. Dye
Chief Growth Officer and Director

David Dye, Chief Growth Officer joined CPSI in 1990. David currently serves on the company’s Board of Directors and was Chairman of the Board from 2006-2018. Prior to becoming Chief Growth Officer, he served in several other executive positions, including President and CEO from 1999-2006 and the position of CFO from 2010-2015. David graduated from the University of the South with a Bachelor of Science in Economics.

Regina M. Benjamin, M.D.
Director

Regina M. Benjamin was elected to the board in November 2017. Dr. Benjamin currently serves as the Chief Executive Officer of, and is a practicing physician, at the Bayou La Batre Rural Health Clinic, known as BayouClinic, Inc. She previously served as the United States Surgeon General and Vice Admiral of the U.S. Public Health Service from 2009 to 2013. In addition to roles as a member of the American Medical Association Board of trustees and the Medical Association of Alabama. Dr. Benjamin is currently a member of the boards of directors of Diplomat Pharmacy, Inc., ConvaTec, and Kaiser Foundation Hospitals and Health Plan.

Chair of the Nominating and Corporate Governance Committee
Member of the Audit Committee 
Member of the Innovation and Technology Committee

Christopher T. Hjelm
Director

Christopher T. Hjelm was elected to the board in December 2019. Chris recently retired after serving 14 years with The Kroger Company, the largest supermarket chain in the United States, where he served most recently as Executive Vice President and Chief Information Officer. He currently serves on the board of Inky Technology Corporation and on the investment committees for Connetic Ventures and Cintrifuse. He previously served on the board of Kindred Healthcare, a publicly traded healthcare services company that through its subsidiaries operated hospitals and nursing homes and provided home health, hospice and other non-medical services. Hjelm also served on the board of RehabCare, a healthcare services company that provided therapy services across multiple settings.

Chair of the Innovation and Technology Committee
Member of the Compensation Committee

Charles P. Huffman
Director

Charles P. Huffman was first elected as a director at the 2004 annual meeting. Prior to his retirement in 2008, Mr. Huffman served as Executive Vice President and Chief Financial Officer of EnergySouth, Inc., where he also served as Senior Vice President, Chief Financial Officer and Treasurer from 1998 to 2001, and Senior Vice President and Chief Financial Officer from 2001 to 2007.

Financial Expert
Chair of the Audit Committee
Member of the Nominating and Corporate Governance Committee

W. Austin Mulherin
Director

W. Austin Mulherin, III, became a director in 2002. Mr. Mulherin has practiced law, handling a variety of litigation and business matters for public and private companies since 1991. He has been a partner in the law firm of Frazer, Greene, Upchurch & Baker, LLC, since 1998. Mr. Mulherin served on the board of directors of the predecessor company to CPSI (predating CPSI’s initial public offering in 2002) and has extensive knowledge of CPSI and its operations.

Denise W. Warren
Director

Denise W. Warren was elected as a director in 2017. Ms. Warren served as the Executive Vice President and Chief Operating Officer of WakeMed Health & Hospitals from 2015 to January 2021 when she announced her retirement.  She began her career in 1980 with Ernst & Whinney (Ernst & Young), and worked for a series of financial firms including E.F. Hutton, Ford Capital, LTD, CS First Boston and Merrill Lynch & Co. before joining Capella Healthcare, Inc., as Chief Financial Officer. Ms. Warren also served as a Senior Vice President and Chief Financial Officer of Gaylord Entertainment Company, and Senior Equity Analyst and Research Director for Avondale Partners LLC. She currently serves as a member of the boards of directors for HeartCare+ and CancerCare+, collaborations with Duke University Health System, and Rockroom Insurance Group. Ms. Warren also serves on the Vizient Central Atlantic Executive Board. She previously served on the boards of directors of American Heart Association – Middle Tennessee and the Federation of American Hospitals.



Member of the Audit Committee
Member of the Innovation and Technology Committee